Healthcare Sector

Members of Parliament invested in the Healthcare Sector

157 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£176.41	307.98%	£285,585.10
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£176.41	282.42%	£267,693.47
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£12,888.00	7.19%	£75,029.94
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£12,888.00	213.12%	£219,183.67
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£15,316.00	295.10%	£276,569.07**
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£12,888.00	73.65%	£121,552.14
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£12,888.00	9.46%	£76,623.07
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£12,888.00	383.33%	£338,331.15
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£12,888.00	6.02%	£74,215.20
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£12,888.00	137.92%	£166,542.37
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£12,888.00	8.08%	£75,659.17
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£12,888.00	25.98%	£88,187.68
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£12,888.00	61.00%	£112,699.56
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£12,888.00	338.67%	£307,066.03
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£4.98	50.45%	£105,317.22
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£51.98	39.02%	£97,314.79
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£56.69	6.10%	£74,271.01**
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£51.98	21.51%	£85,053.76
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£51.98	32.00%	£92,397.15
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£51.98	22.86%	£85,998.58
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£51.98	31.63%	£92,139.78
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£51.98	16.16%	£81,309.50
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£51.98	18.08%	£82,657.88
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£51.98	39.10%	£97,366.87
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£265.95	61.15%	£112,806.77
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£265.95	116.85%	£151,797.95
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£265.95	265.87%	£256,108.14
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£265.95	336.48%	£305,539.16
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£265.95	64.45%	£115,115.64
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£196.50	172.33%	£190,633.24
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£198.61	-20.20%	£55,860.39**
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£417.64	64.93%	£115,452.18
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£379.86	-22.49%	£54,259.07**
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£409.25	-23.91%	£53,264.97**
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£417.64	-19.41%	£56,416.06
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£417.64	-29.74%	£49,183.71
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,336.29	98.71%	£139,095.46
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£559.53	33.81%	£93,669.83
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£559.53	21.84%	£85,286.78
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£559.53	-4.13%	£67,108.32
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£559.53	20.84%	£84,586.86
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£475.66	-0.37%	£69,743.41**
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£108.50	-82.29%	£12,397.98
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£108.50	-66.09%	£23,734.38
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£49.67	36.64%	£95,650.62
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£49.67	-51.16%	£34,191.17
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£49.67	-59.54%	£28,325.05
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£49.67	-63.11%	£25,819.84
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£76.92	-54.24%	£32,030.93
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£76.92	-52.76%	£33,069.65
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£156.11	76.63%	£123,644.49
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£156.11	136.36%	£165,449.92
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£156.11	188.87%	£202,210.47
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£231.50	1.76%	£71,230.77
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£321.70	27.73%	£89,414.34
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£321.70	3.89%	£72,724.05
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£321.70	25.76%	£88,033.62
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£321.70	6.17%	£74,320.13
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£321.70	4.11%	£72,877.03
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£104.49	313.56%	£289,488.73
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£104.49	-3.98%	£67,214.67
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£104.49	217.60%	£222,319.13
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£14.56	-85.61%	£10,071.15
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£24.67	26.22%	£88,356.92
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£24.67	-15.00%	£59,501.56
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£31.12	37.67%	£96,367.88
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£31.12	48.33%	£103,830.28
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£371.20	326.23%	£298,358.04
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£336.74	385.08%	£339,553.44
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£336.74	22.45%	£85,715.63
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£52.10	9.00%	£76,297.07
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£52.10	-5.19%	£66,369.42
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£22.22	73.46%	£121,420.76
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£84.22	-16.42%	£58,503.53
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£107.07	34.78%	£94,346.67
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£47.23	-50.42%	£34,706.07
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£168.05	-38.61%	£42,971.69
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£256.91	59.76%	£111,831.98
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£356.83	28.43%	£89,897.78
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£356.83	1.72%	£71,205.28
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£356.83	-35.27%	£45,307.64
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29**
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£389.62	1,156.03%	£879,219.85
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£25.50	1.96%	£71,370.88
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,220.00	-17.10%	£58,028.38
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£556.20	1,756.48%	£1,299,532.78
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,197.53	63.75%	£114,622.81
Apr '26	Lord Grabiner	Eli Lilly / NYQ:LLY	£955.19	£1,197.53	25.37%	£87,759.61
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,577.00	-22.16%	£54,486.67
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£0.67	-98.44%	£1,089.86
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£1,053.20	89.08%	£132,359.06
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£9.96	611.43%	£498,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£3.27	70.31%	£119,218.75
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.56	-46.15%	£37,692.31
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£55.75	270.43%	£259,302.33
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14**
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.29	-97.61%	£1,672.53
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£18.64	75.52%	£122,862.52
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£9.85	-12.44%	£61,288.89
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£58.73	95.25%	£136,672.21
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£55.63	-50.32%	£34,774.96
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£370.20	10.15%	£77,102.05
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£4.30	-66.01%	£23,794.47
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£165.40	-20.29%	£55,797.59
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£165.40	-39.46%	£42,379.21
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.35	-98.65%	£942.31
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£69.00	-38.39%	£43,125.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£69.00	33.98%	£93,786.41
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£115.07	558.67%	£461,070.43
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£1.14	-96.20%	£2,660.00
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.44	-12.91%	£60,962.03

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.